Nomura Holdings’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-83,450
Closed -$12.3M 1465
2025
Q1
$12.3M Buy
+83,450
New +$12.1M 0.02% 425
2015
Q1
Sell
-134,000
Closed -$9.45M 1758
2014
Q4
$9.45M Sell
134,000
-2,492,000
-95% -$178M 0.03% 375
2014
Q3
$188M Buy
2,626,000
+2,025,500
+337% +$148M 0.51% 40
2014
Q2
$44.6M Buy
600,500
+550,500
+1,101% +$39.8M 0.01% 174
2014
Q1
$3.24M Buy
+50,000
New +$3.23M ﹤0.01% 931

Other funds holding AZN

Nomura Holdings's AZN Position: Q2 2026 in Review

Nomura Holdings opened a new position in AstraZeneca (AZN) in Q2 2026: 95,936 shares worth $18.2M. The stake represents 0.02% of the portfolio and ranks #385 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in AZN as recently as Q4 2025.

Nomura Holdings first reported a position in AZN in Q3 2013 and has held it in 22 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Nomura Holdings held 95,936 shares of AstraZeneca worth $18.2M as of Q2 2026.
  • AstraZeneca was a new Nomura Holdings position in Q2 2026.
  • AstraZeneca made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #385 holding.
  • Nomura Holdings first reported a position in AstraZeneca in Q3 2013 and has held it in 22 quarters since.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.